Skip to main content
OpenTrials
Completed

NCT Number: NCT03350919

Visual Restoration for Hemianopia

The purpose of this research is to assess the efficacy of a visual training task on reducing the size of a visual field deficit caused by brain damage in adults, and its ability to improve visual functions in this patient population.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Bascom Palmer Eye Institute, University of Miami Health Services, Miami, Florida, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ages 21-75 years old
  • Ability and willingness to sign informed consent
  • Willingness to participate in both the training and evaluation sessions
  • MRI or CT scan demonstrating lesion in the occipital lobe of the brain and/or affecting white matter tracts that provide visual input to the occipital lobe of the brain
  • Brain injury due to ischemic or hemorrhagic causes that occurs after age 18 and at least 90 days prior to screening visit
  • At least two reliable HVF's demonstrating good fixation and a stable homonymous incomplete (e.g., quadrantanopia or relative defect) or complete hemianopia
  • Reliable HVFs with repeat HVFs if randomization takes place more than 4 weeks after screening visit
  • A homonymous, contiguous visual deficit measured by the 24-2 HVF to be a minimum of two testing locations high and two testing locations wide, where impaired locations are any that measure a threshold of less than 15 dB.
  • Demonstration of good fixation on visual training task - able to fixate the small targets presented as fixation letters reliably for 1000ms with jitter over less than 1 degree of visual angle in any direction away from target edge

Exclusion criteria

  • Physical, neurological or mental disability that would interfere with study intervention
  • Concurrent participation in "vision therapy" other than standard occupational or physical therapy
  • Unreliable visual fields on prior testing, indicated by greater than 20% fixation losses, false positives, or false negatives.
  • Inability to discontinue medications judged to affect training and/or assessment (e.g., Ritalin, amphetamines, dopamines, or chemotherapeutic agents)
  • Physical condition likely to preclude completion of the clinical trial (e.g. end-stage or uncontrolled cancer, uncontrolled epilepsy, or end-stage heart disease)
  • Ocular or neurological condition that would interfere with training or assessment (e.g. damage to the optic nerves or lateral geniculate nucleus, any degenerative ocular condition)
  • Best corrected vision worse than 20/40
  • Impaired foveal Humphrey sensitivity as indicated by the HVF tests.
  • Presence of vision loss resulting from ocular disease or disorder
  • Presence of bilateral visual acuity loss from any source
  • Inability to demonstrate fixation stability on eye movement monitored testing
  • Inability to follow training instructions

Treatment and study plan

Training in the blind field

Device

A computer software and chin-rest necessary to perform visual training will be loaned to each patient to use at home. They will perform one to two daily training sessions in their home, consisting of 200-300 trials each. The visual task performed repetitively will involve discriminating the direction of motion of a small cloud of dots located at a pre-determined location in the blind field. The computer program will automatically create a record of patient performance during each home training session. They will train daily (about 40-60 minutes total), 5 to 7 days per week, for at least 24 weeks.

Training in the intact field

Device

A computer software and chin-rest necessary to perform visual training will be loaned to each patient to use at home. They will perform one to two daily training sessions in their home, consisting of 200-300 trials each. The visual task performed repetitively will involve discriminating the direction of motion of a small cloud of dots located at a pre-determined location in the intact field of vision. The computer program will automatically create a record of patient performance during each home training session. They will train daily (about 40-60 minutes total), 5 to 7 days per week, for at least 24 weeks.

Primary outcomes

  1. 24-2 Humphrey PMD Change From Baseline to 6-month Post-training Timepoint

    Time frame: 6 months

    Change in the perimetric mean deviation (PMD) generated by standard Humphrey automated perimetry using a 24-2 testing pattern between baseline and post-training after a 6-month training interval.

Sponsors and collaborators

Lead sponsor

University of Rochester

Other

Collaborators

  • Envision Solutions, LLC

Registry information

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Nov 22, 2017
Registry last updated
Dec 24, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.